US Specialty Pharmaceutical Market Trends and Developments | Amgen, Pfizer, Johnson & Johnson and Merck and Co.

Recent released and technology insights on “US Specialty Pharmaceutical Market”
Specialty pharmaceuticals are typically high-cost, scientifically engineered drugs used to treat complex, chronic conditions that require special storage, warranting special handling, and temperature-control monitoring. These products are often manufactured for small populations of people suffering from somewhat rare, life-threatening and debilitating diseases. The specialty pharmaceuticals are mostly injectable or infused medicines but may also encompass oral medications.
Currently, specialty drugs are one of the fastest growing segments of the overall pharmaceutical market, as sales growth is being driven by improved efficacy compared with currently marketed therapies, while expanded indications for already marketed drugs and off label prescribing can drive sales of these drugs by increasing potential patient populations. The key factors driving growth of the US specialty pharmaceutical industry include accelerating US aging population, ameliorating economic condition, increased life expectancy, and increasing healthcare expenditure. Apart from these growth drivers, many challenges lie ahead for the specialty pharmaceutical market in the US, including the changes in reimbursement process due to healthcare reforms, regulatory pressures, narrowing specialty pharmacy networks and lack of access to specialty pharmacy products.
Some of the noteworthy trends and developments of this industry include novel specialty product launches, growing Hepatitis-C segment, increased spending on specialty drugs and ongoing merger & acquisition activities. The percentage of specialty pharmaceuticals sales of the overall US pharmaceuticals sales continues to rise.
The report, “The US Specialty Pharmaceuticals Market: 2015 Edition” analyzes the growth and development of specialty pharmaceutical in the US. Apart from providing a competitive landscape of the market, the report also profiles the major companies including Amgen, Pfizer, Johnson & Johnson and Merck and Co., along with a discussion of their key financials and business strategies.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests. 
Table of Content
1. Overview
1.1 Specialty Pharmaceuticals Vs Traditional Drugs
1.2 Applications of Specialty Pharmaceuticals
1.3 Specialty Pharmacy Services
1.3.1 Packaging and Delivery Services
1.3.2 Reimbursement Services
1.3.3 Inbound and Outbound Clinical Support
1.3.4 Compliance and Persistence Program
1.4 Specialty Product Distribution
1.4.1 Distribution Services
1.5 Specialty Pharma Manufacturer Services
1.6 Value Proposition of Specialty Pharmacy
2. The US Specialty Pharmaceutical Market
  • Market Value
  • Traditional Vs Specialty 
  • Sales by Dispensing Channels
2.1 The US Specialty Market by Therapeutic Area
2.2 Specialty Pharmacy in the US
3. Market Dynamics
3.1 Key Trends and Developments
3.1.1 PBM Mergers and Acquisitions
3.1.2 Increased Specialty Drug Spend
3.1.3 Increasing Number of Specialty Pharmacy Providers
3.1.4 Oncology: No Longer Fastest Growing Specialty Sector
3.1.5 New Product Launches
3.2 Growth Drivers
3.2.1 Accelerating US Aging Population
3.2.2 Increasing Life Expectancy Rate in the US
3.2.3 Rising Incidences of Complex Chronic and Infectious Diseases
3.2.4 Rising Pharmaceutical Sales
3.2.5 Escalating Healthcare Expenditure in the US
3.2.6 Ameliorating Economic Conditions
3.2.7 Rising Medicare Enrollments
3.3 Challenges
3.3.1 Intensifying Pricing Pressure
3.3.2 Narrowing Specialty Pharmacy Networks
3.3.3 Lack of Access to Specialty Pharmacy Products
3.3.4 Regulatory Issues
3.4 Specialty Pharmaceuticals: Pipeline Update
4. Competitive Landscape
4.1 Competition by Drugs
4.2 Competition by Mail Pharmacy
4.3 Competition by Specialty Distributor
5. Company Profiles
5.1 Johnson & Johnson
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
  • New Product Launch
  • Pursue Strategic Acquisitions
5.2 Amgen Inc.
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
  • Global Expansion 
  • Growth through Acquisitions
5.3 Merck & Co.
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
  • Augmented Research and Development
  • Research Collaborations and License Agreements
5.4 Pfizer Inc.
5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Business Strategies
  • Focus on Unmet Needs of Patients 
  • Pioneering New Collaborations
6. Market Outlook
6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis 

Media Contact
Company Name: MarketResearchReports.Biz
Contact Person: Rohit Bhisey
Phone: +1-518-621-2074
Address:State Tower 90 State Street, Suite 700
City: Albany
State: NY 12207
Country: United States